Induced pluripotent stem cells: developmental biology to regenerative medicine (Q37801268)

23 August 2017

Induced pluripotent stem cells: developmental biology to regenerative medicine (English)

1 reference

23 August 2017

regenerative medicine

1 reference

based on heuristic

inferred from title

developmental biology

1 reference

Timothy J Nelson

1

1 reference

23 August 2017

Almudena Martinez-Fernandez

series ordinal

2

1 reference

23 August 2017

Andre Terzic

series ordinal

3

1 reference

23 August 2017

language of work or name

English

0 references

publication date

19 October 2010

1 reference

Nature Reviews Cardiology

23 August 2017

1 reference

23 August 2017

7

1 reference

23 August 2017

700-710

1 reference

23 August 2017

12

1 reference

https://scigraph.springernature.com/pub.10.1038/nrcardio.2010.159

23 August 2017

0 references

cites work

Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

Induced pluripotent stem cell lines derived from human somatic cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

Induction of pluripotent stem cells from adult human fibroblasts by defined factors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

Direct reprogramming of genetically unmodified fibroblasts into pluripotent stem cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

Disease-specific induced pluripotent stem cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

Stem cells, the molecular circuitry of pluripotency and nuclear reprogramming

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

Differentiation of embryonic stem cells to clinically relevant populations: lessons from embryonic development

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

Strategies and new developments in the generation of patient-specific pluripotent stem cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

Generation of human-induced pluripotent stem cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

Nuclear reprogramming to a pluripotent state by three approaches

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

Stem cells: biologics for regeneration.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

Strategies for therapeutic repair: The "R(3)" regenerative medicine paradigm.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

Stem cell platforms for regenerative medicine

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

Current perspectives on imaging cardiac stem cell therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

Diagnosis of post-transplant lymphoproliferative disorder in solid organ transplant recipients - BCSH and BTS Guidelines.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

Molecular and immunologic mechanisms of cancer pathogenesis in solid organ transplant recipients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

31 March 2020

Capturing pluripotency

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

Sheep cloned by nuclear transfer from a cultured cell line

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

Interspecies nuclear transfer: implications for embryonic stem cell biology

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

Producing primate embryonic stem cells by somatic cell nuclear transfer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

Development of human cloned blastocysts following somatic cell nuclear transfer with adult fibroblasts

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

Pluripotency and nuclear reprogramming

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

A fresh look at iPS cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

Elite and stochastic models for induced pluripotent stem cell generation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

Induced pluripotent stem cells from a spinal muscular atrophy patient

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

Induction of pluripotent stem cells from fibroblast cultures.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

Differentiation stage determines potential of hematopoietic cells for reprogramming into induced pluripotent stem cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

Feeder-free derivation of induced pluripotent stem cells from adult human adipose stem cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

Telomeres acquire embryonic stem cell characteristics in induced pluripotent stem cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

Targeted bisulfite sequencing reveals changes in DNA methylation associated with nuclear reprogramming

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

Dissecting direct reprogramming through integrative genomic analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

Nanog is the gateway to the pluripotent ground state.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

Hypoxia enhances the generation of induced pluripotent stem cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

A chemical platform for improved induction of human iPSCs

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

Senescence impairs successful reprogramming to pluripotent stem cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

Immortalization eliminates a roadblock during cellular reprogramming into iPS cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

A p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

The Ink4/Arf locus is a barrier for iPS cell reprogramming

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

Linking the p53 tumour suppressor pathway to somatic cell reprogramming

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

Suppression of induced pluripotent stem cell generation by the p53-p21 pathway

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

Dynamic single-cell imaging of direct reprogramming reveals an early specifying event

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

Direct cell reprogramming is a stochastic process amenable to acceleration

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

Retroviral vector silencing during iPS cell induction: an epigenetic beacon that signals distinct pluripotent states

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

Induced pluripotent stem cells generated without viral integration

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

Generation of mouse induced pluripotent stem cells without viral vectors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

Polycistronic lentiviral vector for "hit and run" reprogramming of adult skin fibroblasts to induced pluripotent stem cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

Virus-free induction of pluripotency and subsequent excision of reprogramming factors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

Human induced pluripotent stem cells free of vector and transgene sequences

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

Generation of induced pluripotent stem cells using recombinant proteins

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

Reprogrammed mouse fibroblasts differentiate into cells of the cardiovascular and hematopoietic lineages

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

iPS programmed without c-MYC yield proficient cardiogenesis for functional heart chimerism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

Generation of functional murine cardiac myocytes from induced pluripotent stem cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

Directed and systematic differentiation of cardiovascular cells from mouse induced pluripotent stem cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

Efficient adipocyte and osteoblast differentiation from mouse induced pluripotent stem cells by adenoviral transduction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

Orderly hematopoietic development of induced pluripotent stem cells via Flk-1(+) hemoangiogenic progenitors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

Characterization of dendritic cells and macrophages generated by directed differentiation from mouse induced pluripotent stem cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

Generation of pluripotent stem cells from patients with type 1 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

Generation of insulin-secreting islet-like clusters from human skin fibroblasts

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

Highly efficient differentiation of human ES cells and iPS cells into mature pancreatic insulin-producing cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

Highly efficient generation of human hepatocyte-like cells from induced pluripotent stem cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

Efficient generation of hepatocyte-like cells from human induced pluripotent stem cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

Derivation of functional retinal pigmented epithelium from induced pluripotent stem cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

Modeling early retinal development with human embryonic and induced pluripotent stem cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

In vitro differentiation of retinal cells from human pluripotent stem cells by small-molecule induction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

Directed differentiation of human-induced pluripotent stem cells generates active motor neurons

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

Pluripotency: toward a gold standard for human ES and iPS cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

KCNJ11 knockout morula re-engineered by stem cell diploid aggregation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

Production of mouse chimeras by aggregating pluripotent stem cells with embryos

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

iPS cells produce viable mice through tetraploid complementation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

Aberrant silencing of imprinted genes on chromosome 12qF1 in mouse induced pluripotent stem cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

Phenotypic correction of murine hemophilia A using an iPS cell-based therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

Repair of acute myocardial infarction by human stemness factors induced pluripotent stem cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

Human-induced pluripotent stem cells from blood cells of healthy donors and patients with acquired blood disorders

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

Cardiogenesis and the complex biology of regenerative cardiovascular medicine

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

Origin of stem cells in organogenesis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

A common progenitor at the heart of development

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

31 March 2020

Regenerating the heart

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

Origins and fates of cardiovascular progenitor cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

Differentiation of human embryonic stem cells to cardiomyocytes: role of coculture with visceral endoderm-like cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

Wnt antagonism initiates cardiogenesis in Xenopus laevis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

Inhibition of Wnt activity induces heart formation from posterior mesoderm

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

Development. The path to the heart and the road not taken.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

Nkx2-5 pathways and congenital heart disease; loss of ventricular myocyte lineage specification leads to progressive cardiomyopathy and complete heart block

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

Developmental Changes in Ventricular Diastolic Function Correlate With Changes in Ventricular Myoarchitecture in Normal Mouse Embryos

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

Epicardial progenitors contribute to the cardiomyocyte lineage in the developing heart.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

Tbx18 and the fate of epicardial progenitors.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

A molecular pathway including Id2, Tbx5, and Nkx2-5 required for cardiac conduction system development

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

Neuregulin-1 promotes formation of the murine cardiac conduction system

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

Developmental changes in contractility and sarcomeric proteins from the early embryonic to the adult stage in the mouse heart

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

Genetic dissection of cardiac growth control pathways

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

Generation and characterization of functional cardiomyocytes using induced pluripotent stem cells derived from human fibroblasts

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

Functional characterization of cardiomyocytes derived from murine induced pluripotent stem cells in vitro

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

c-MYC independent nuclear reprogramming favors cardiogenic potential of induced pluripotent stem cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

Cardiomyocyte differentiation of human induced pluripotent stem cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

Mouse and human induced pluripotent stem cells as a source for multipotent Isl1+ cardiovascular progenitors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

The effects of cardioactive drugs on cardiomyocytes derived from human induced pluripotent stem cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

Cardiac myocytes derived from murine reprogrammed fibroblasts: intact hormonal regulation, cardiac ion channel expression and development of contractility.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

Patient-specific induced pluripotent stem-cell models for long-QT syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

Patient-specific induced pluripotent stem-cell-derived models of LEOPARD syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

Development of a drug screening platform based on engineered heart tissue

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

Reporter-based isolation of induced pluripotent stem cell- and embryonic stem cell-derived cardiac progenitors reveals limited gene expression variance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

Cytokines and myocardial regeneration: a novel treatment option for acute myocardial infarction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

Cardiogenic differentiation and transdifferentiation of progenitor cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

Delivery of Biologics in Cardiovascular Regenerative Medicine

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

A purified population of multipotent cardiovascular progenitors derived from primate pluripotent stem cells engrafts in postmyocardial infarcted nonhuman primates.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

Geron gets green light for human trial of ES cell-derived product.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

Critical issues of clinical human embryonic stem cell therapy for brain repair

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

A decade of discoveries in cardiac biology

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

Guided stem cell cardiopoiesis: discovery and translation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

Cardiopoietic programming of embryonic stem cells for tumor-free heart repair

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

Cardiogenic induction of pluripotent stem cells streamlined through a conserved SDF-1/VEGF/BMP2 integrated network

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

CXCR4+/FLK-1+ biomarkers select a cardiopoietic lineage from embryonic stem cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

Multipotent embryonic isl1+ progenitor cells lead to cardiac, smooth muscle, and endothelial cell diversification

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

Multipotent flk-1+ cardiovascular progenitor cells give rise to the cardiomyocyte, endothelial, and vascular smooth muscle lineages

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

Directed transdifferentiation of mouse mesoderm to heart tissue by defined factors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

Cardiac progenitor cells and biotinylated insulin-like growth factor-1 nanofibers improve endogenous and exogenous myocardial regeneration after infarction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

Regenerative medicine advancing health care 2020

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

Recent stem cell advances: induced pluripotent stem cells for disease modeling and stem cell-based regeneration

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.159

Functional cardiomyocytes derived from human induced pluripotent stem cells

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20956984

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/NRCARDIO.2010.159

1 reference

Dimensions Publication ID

23 August 2017

0 references

1 reference